Company: KVACU
Filing Date: 2025-03-07
Form Type: 10-K
Source: 0001213900-25-021314
Chunk: 348

Company: Keen Vision Acquisition Corp.
Filing Date: 2025-03-07
Form: 10-K
Item: Item 2
Chunk 348
---
 diagnostic company Hai Kang Life Corporation Ltd since May 1999.

Concurrently, Prof. Yu serves
roles in 22 companies and organizations, including RNA interference (RNAi) therapeutics biopharmaceutical company Sirnaomics Ltd (independent
non-executive director since July 2021), venture capital fund CR-CP Life Science Fund Management Limited (independent director since May
2021), international biotech convention organizer BIOHK Limited (director since February 2019), the Biotech Advisory panel of the Stock
Exchange of Hong Kong Limited (HKEX) (panel member since April 2018), the Guangdong-Hong Kong-Macao Greater Bay Area Biotechnology Alliance
(GBABA) (director, founder and chairman since December 2017), the Glia and Neuro-diseases Committee of the Beijing Society for Neuroscience
(BJSN) (director since December 2017), nonprofit international scientific conferences organizer, Gordon Research Conferences (member of
the Board of Trustees since May 2016), the Asian Fund for Cancer Research Limited (director since July 2011), Hong Kong

Biotechnology Organization
(HKBIO) (founder and chairman since September 2009), Hong Kong DNA Chips Ltd (director since April 2007), and clinical diagnostic firm
Hai Kang Life Corp. Ltd.’s subsidiary DNA-Tech Ltd (director since February 2002).

30

His past directorships of
corporate and academic organizations include the Chinese Neuroscience Society (CNS) (vice director from October 2015 to October 2019),
Hong Kong Science and Technology Parks Limited (HKSTP) (director from July 2011 to June 2017), the Beijing Society for Neuroscience (BJSN)
(director from January 2008 to December 2013), and the key neuroscience laboratory designated by the Chinese Ministry of Education and
Ministry of Health; the Neuroscience Research Institute of Peking University (vice director from December 2006 to December 2018).

Concurrently to his current
role at Peking University, from September 2006 to December 2017, Prof. Yu was a professor at the Peking University Infectious Disease
Research Center. Prior to that, from February 1994 to December 2001, Prof. Yu was a lecturer and assistant professor at the Hong Kong
University of Science and Technology (HKT). From February 1994 to August 1996, he was also a visiting associate professor at Stanford
University,